← All organizations

Osmotica Pharmaceutical

For profitWebsite ↗

Also known as: OSMOTICA | OSMOTICA PHARM | Osmotica Pharmaceutical Argentina S.A. | Osmotica Pharmaceutical US LLC | Osmotica Pharmaceutical, VP - Global Clinical Development and Medical Affairs | OSMOTICA PHARM CORP | OSMOTICA PHARM US | RevitaLid Inc. | RVL Pharmaceuticals, Inc. | RVL PHARMA INC | RVL PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Oct 22, 2024

Timeline

2000s

Jun 1, 2000
Osmotica Pharmaceutical— Founded

2010s

Dec 4, 2015
Trigen— Acquired
Dec 4, 2015
Vertical Pharmaceuticals— Acquired
Jul 28, 2017
methylphenidate— Marketing Organization
Feb 16, 2018
amantadine— NDA Secondary Org

Drugs by trial phase (7 distinct, 14 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (0 own, 1 via acquisition)

revacept

Indications

Studied for

Marketed drugs (13)

Subsidiaries (2 direct, 3 total across the full acquisition tree)

Recent trials (19)

NCT05179577Lead sponsorPhase 3Jan 31, 2023
NCT03565887Lead sponsorPhase 3Jun 28, 2018
NCT03536949Lead sponsorPhase 3Jun 20, 2018
NCT03319732Lead sponsorPhase 3Apr 3, 2018
NCT03290131Lead sponsorPhase 3Jan 28, 2018
NCT02869425Lead sponsorPhase 3Jul 1, 2016
NCT02869425Study chairPhase 3Jul 1, 2016
NCT02436759Lead sponsorPhase 3May 1, 2015
NCT02153645Study chairPhase 3Jun 1, 2014
NCT02153632Study chairPhase 3Jun 1, 2014
NCT02153632Lead sponsorPhase 3Jun 1, 2014
NCT02153645Lead sponsorPhase 3Jun 1, 2014
NCT01848041Lead sponsorPhase 1/Phase 2May 1, 2013
NCT01844232Lead sponsorPhase 3Apr 1, 2013
NCT01844232Study chairPhase 3Apr 1, 2013

Details

Founded: Marietta, GA, US Jun 1, 2000
Last known activity: Oct 22, 2024